Advertisement

Re: Urodynamic evaluation of the efficacy of vibegron, a new β3-adrenergic receptor agonist, on lower urinary tract function in children and adolescents with overactive bladder

  • Changkai Deng
    Correspondence
    Correspondence to: Changkai Deng, Department of Pediatric Surgery, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China, Tel.: +86 15882420198; fax: +86 28 61866051
    Affiliations
    Department of Pediatric Surgery, Chengdu Women's and Children 's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China
    Search for articles by this author
  • Rong Dai
    Affiliations
    Chengdu Center for Disease Control and Prevention, Chengdu, 610041, China
    Search for articles by this author
  • Yue Chen
    Affiliations
    Chengdu Center for Disease Control and Prevention, Chengdu, 610041, China
    Search for articles by this author
Published:September 21, 2022DOI:https://doi.org/10.1016/j.jpurol.2022.09.003
      We read with great interest the recent contribution of Dr. Kitta et al. in their study, entitled “Urodynamic evaluation of the efficacy of vibegron, a new β3-adrenergic receptor agonist, on lower urinary tract function in children and adolescents with overactive bladder” [
      • Kitta T.
      • Chiba H.
      • Kon M.
      • Higuchi M.
      • Kusakabe N.
      • Ouchi M.
      • et al.
      Urodynamic evaluation of the efficacy of vibegron, a new β3-adrenergic receptor agonist, on lower urinary tract function in children and adolescents with overactive bladder.
      ]. They showed that treatment with vibegron significantly improved clinical and urodynamic parameters of pediatric OAB with no adverse effects. However, we would like to contribute some points regarding their paper.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kitta T.
        • Chiba H.
        • Kon M.
        • Higuchi M.
        • Kusakabe N.
        • Ouchi M.
        • et al.
        Urodynamic evaluation of the efficacy of vibegron, a new β3-adrenergic receptor agonist, on lower urinary tract function in children and adolescents with overactive bladder.
        J Pediatr Urol. 2022; (S1477–5131(22)316-323)
        • Austin P.F.
        • Bauer S.B.
        • Bower W.
        • Chase J.
        • Franco I.
        • Hoebeke P.
        • et al.
        The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society.
        Neurourol Urodyn. 2016; 35: 471-481
        • Austin P.F.
        Stepwise treatment for overactive bladder is prudent.
        Can Urol Assoc J. 2017; 11: S80
        • Nieuwhof-Leppink A.J.
        • Hussong J.
        • Chase J.
        • Larsson J.
        • Renson C.
        • Hoebeke P.
        • et al.
        Definitions, indications and practice of urotherapy in children and adolescents: - a standardization document of the International Children's Continence Society (ICCS).
        J Pediatr Urol. 2021; 17: 172-181
        • Chang S.J.
        • Van Laecke E.
        • Bauer S.B.
        • von Gontard A.
        • Bagli D.
        • Bower W.F.
        • et al.
        Treatment of daytime urinary incontinence: a standardization document from the International Children's Continence Society.
        Neurourol Urodyn. 2017; 36: 43-50

      Linked Article